Chinese pharmaceutical company EU market analysis and strategic business development
LCPS bring the extensive experience to help Chinese pharmaceutical company to enter EU market; enterprises seize market opportunities and obtain maximum profits for sustainable development in EU market.
We aim to enable Chinese capable pharmaceutical companies directly or collaborate with EU companies to launch the products to EU market or expand the product line through partnership, Joint venture or merger and acquisition. We will help companies to define EU market potential by identifying market position and market capability of providing the quickest returns. We will help you assess EU market attractiveness and establish EU market entry priorities according to the economic or social and political factors affecting EU healthcare market, local regulatory requirements, distribution channels, partner selection and competition. With in-depth research, we will be able to develop, recommend and implement EU healthcare market entry strategies to meet your company's objectives.

Our services are specialised in:

  • Market Opportunity Assessment and Market research
  • Market Entry Strategy
  • Regulatory Clearance strategy
  • Strategy Business Development
      > Partnership selection and evolution
      > Distributor and channel management